The Temporal Relationship Between Medicaid Payment Acceptance and the Implementation of Medication-Assisted Drug Treatment

被引:0
|
作者
Guerrero, Erick G. [1 ,2 ]
Garner, Bryan R. [3 ]
Cook, Benjamin [4 ]
Kong, Yinfei [5 ]
Vega, William A. [1 ,2 ]
机构
[1] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, 655 West 34th St, Los Angeles, CA 90089 USA
[2] Univ Southern Calif, Marshall Sch Business, 655 West 34th St, Los Angeles, CA 90089 USA
[3] RTI Int, Durham, NC USA
[4] Harvard Med Sch, Dept Psychiat, Boston, MA USA
[5] Calif State Univ Fullerton, Mihaylo Coll Business & Econ, Fullerton, CA 92634 USA
来源
关键词
Evidence-based practices; medication-assisted treatment; contingency management; racial and ethnic groups;
D O I
10.1177/1178221818811314
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
OBJECTIVE: To examine the temporal relationship of Medicaid funding on the implementation of evidence-based practices (EBPs) in outpatient substance use disorder (SUD) treatment. METHODS : We examined data from 61 publicly funded SUD treatment programs in 2011 and 2013 using crossed-lagged regressions. We tested the impact of Medicaid payment acceptance on 2 measures of EBP implementation-contingency management treatment (CMT) and medication-assisted treatment (MAT). RESULTS : Medicaid payment acceptance at wave 1 was not associated with implementation of CMT at wave 2 (standardized estimate = 0.170, SE = 0.208, P > .05). However, Medicaid payment acceptance at wave 1 was associated with implementation of MAT at wave 2 (standardized estimate = 0.880, SE = 0.047, P < .001). CONCLUSIONS: Medicaid payment acceptance has a temporal relationship with the implementation of MAT in SUD treatment programs serving one of the largest racial/ethnic minority communities in the United States.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure
    Knudsen, Hannah K.
    Abraham, Amanda J.
    Oser, Carrie B.
    [J]. EVALUATION AND PROGRAM PLANNING, 2011, 34 (04) : 375 - 381
  • [42] Psychiatrist Characteristics That Influence Use of Buprenorphine Medication-Assisted Treatment
    Albright, Joann
    Ciaverelli, Robert
    Essex, Alyson
    Tkacz, Joseph
    Ruetsch, Charles
    [J]. JOURNAL OF ADDICTION MEDICINE, 2010, 4 (04) : 197 - 203
  • [43] Enhancing Medication-Assisted Treatment: Success Beyond Harm Reduction
    Rabinowitz, Asher
    [J]. JOURNAL OF SOCIAL WORK PRACTICE IN THE ADDICTIONS, 2009, 9 (02) : 240 - 243
  • [44] The Advantages and Disadvantages of Medication-Assisted Treatment in Primary Care Offices
    Padgett, Tonja M.
    [J]. JOURNAL OF ADDICTIONS NURSING, 2019, 30 (04) : 238 - 241
  • [45] Successful Medication-Assisted Treatment Program at a Community Emergency Department
    Reuter, Q.
    Smith, G.
    McKinnon, J.
    Varley, J.
    Jouriles, N.
    Seaberg, D.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S89 - S89
  • [46] Opioid Use Disorders, Medication-Assisted Treatment, and the Role of the Laboratory
    Bertholf, Roger L.
    Reisfield, Gary M.
    [J]. LABORATORY MEDICINE, 2017, 48 (04) : E57 - E61
  • [47] The role of NPs in medication-assisted treatment for opioid use disorder
    Cotton, Brandi Parker
    Ferszt, Ginette G.
    [J]. NURSE PRACTITIONER, 2018, 43 (05): : 8 - 8
  • [48] In Fighting An Opioid Epidemic, Medication-Assisted Treatment Is Effective But Underused
    Vestal, Christine
    [J]. HEALTH AFFAIRS, 2016, 35 (06) : 1052 - 1057
  • [49] Improving Graduation Rates in Drug Court Through Employment and Schooling Opportunities and Medication-Assisted Treatment (MAT)
    Gallagher, John Robert
    Wahler, Elizabeth A.
    Lefebvre, Elyse
    Paiano, Tara
    Carlton, Jesse
    Miller, Jane Woodward
    [J]. JOURNAL OF SOCIAL SERVICE RESEARCH, 2018, 44 (03) : 343 - 349
  • [50] OVERLAP BETWEEN HEPATITIS C VIRUS TREATMENT, MEDICATION-ASSISTED THERAPY AND OPIOID OVERDOSE IN CHICAGO
    Forrest, Jasmine
    Waring, Nicole
    Lee, Todd A.
    Chacra, Wadih
    Martin, Michelle
    [J]. HEPATOLOGY, 2020, 72 : 597A - 598A